CIA
VRTX icon

Choate Investment Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History

Choate Investment Advisors’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.92M Sell
3,862
-75
-2% -$33.2K 0.03% 182
2026
Q1 		$1.76M Sell
3,937
-39
-1% -$18.2K 0.03% 180
2025
Q4 		$1.8M Sell
3,976
-15
-0.4% -$6.46K 0.04% 170
2025
Q3 		$1.56M Sell
3,991
-311
-7% -$130K 0.03% 169
2025
Q2 		$1.92M Sell
4,302
-183
-4% -$84.3K 0.04% 147
2025
Q1 		$2.17M Buy
4,485
+19
+0.4% +$8.85K 0.05% 130
2024
Q4 		$1.8M Buy
4,466
+154
+4% +$71.4K 0.04% 145
2024
Q3 		$2.01M Sell
4,312
-301
-7% -$145K 0.05% 141
2024
Q2 		$2.16M Sell
4,613
-442
-9% -$192K 0.06% 128
2024
Q1 		$2.11M Sell
5,055
-10
-0.2% -$4.23K 0.06% 139
2023
Q4 		$2.06M Buy
5,065
+1,611
+47% +$595K 0.06% 125
2023
Q3 		$1.2M Buy
3,454
+1,132
+49% +$396K 0.05% 139
2023
Q2 		$817K Buy
2,322
+257
+12% +$86.6K 0.03% 161
2023
Q1 		$651K Hold
2,065
– – 0.03% 160
2022
Q4 		$596K Buy
2,065
+113
+6% +$34.4K 0.04% 166
2022
Q3 		$565K Hold
1,952
– – 0.04% 146
2022
Q2 		$550K Buy
1,952
+649
+50% +$174K 0.03% 160
2022
Q1 		$340K Buy
1,303
+64
+5% +$15.2K 0.02% 234
2021
Q4 		$272K Hold
1,239
– – 0.02% 244
2021
Q3 		$225K Sell
1,239
-812
-40% -$159K 0.01% 249
2021
Q2 		$414K Buy
2,051
+805
+65% +$168K 0.03% 193
2021
Q1 		$268K Buy
+1,246
New +$274K 0.02% 229

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Choate Investment Advisors's VRTX Position: Q2 2026 in Review

Choate Investment Advisors reduced its Vertex Pharmaceuticals (VRTX) stake by 1.9% in Q2 2026, selling an estimated $33.2K and leaving 3,862 shares worth $1.92M. The position accounts for 0.03% of the portfolio, ranked #182.

Choate Investment Advisors first reported a position in VRTX in Q1 2021 and has held it in 22 quarters since. The position peaked at $2.17M in Q1 2025. 1,754 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Choate Investment Advisors held 3,862 shares of Vertex Pharmaceuticals worth $1.92M as of Q2 2026.
  • Choate Investment Advisors sold 75 Vertex Pharmaceuticals shares in Q2 2026, an estimated $33.2K.
  • Vertex Pharmaceuticals made up 0.03% of Choate Investment Advisors's portfolio in Q2 2026, its #182 holding.
  • Choate Investment Advisors first reported a position in Vertex Pharmaceuticals in Q1 2021 and has held it in 22 quarters since.
  • Choate Investment Advisors's Vertex Pharmaceuticals position peaked at $2.17M in Q1 2025.
  • 1,754 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Choate Investment Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.